Infectious disease and reproductive health: A review

Obstetrical and Gynecological Survey

Volumn 65, Issue 1, 2010, Pages 53-65

  Baecher Lind, Laura E ^a,b   Miller, William C ^a   Wilcox, Allen J ^c  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c IL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST FEEDING EDUCATION; CHLAMYDIASIS; CYTOMEGALOVIRUS INFECTION; GONORRHEA; HERPES SIMPLEX; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION; MALARIA; MUMPS; PERIODONTAL DISEASE; REPRODUCTIVE HEALTH; REVIEW; RUBELLA; SYPHILIS; TOXOPLASMOSIS; TRICHOMONIASIS; TUBERCULOSIS; VAGINITIS;

COMMUNICABLE DISEASES; CONGENITAL ABNORMALITIES; FEMALE; HUMANS; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; INFERTILITY; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; REPRODUCTION; REPRODUCTIVE MEDICINE; SEXUALLY TRANSMITTED DISEASES;

EID: 73949118439     PISSN: 00297828     EISSN: 15339866     Source Type: Journal    
DOI: 10.1097/OGX.0b013e3181c9e7a1     Document Type: Review

References (128)

1. Garnett GP. The transmission dynamics of sexually transmitted infections. In: Holmes K, Sparling PF, Stamm WE, et al, eds. Sexually Transmitted Infections. 4th ed. New York, NY: McGraw Hill, 2008:27-28.
2. Eley A, Pacey AA, Galdiero M, et al. Can Chlamydia tracho-matis directly damage your sperm? Lancet Infect Dis 2005; 5:53-57.
3. Cunningham KA, Beagley KW. Male genital tract chlamydial infection: implications for pathology and infertility. Biol Re-prod 2008;79:180-189.
4. Veznik Z, Pospisil L, Svecova D, et al. Chlamydiae in the ejaculate: their influence on the quality and morphology of sperm. Acta Obstet Gynecol Scand 2004;83:656-660.
5. Hosseinzadeh S, Eley A, Pacey AA. Semen quality of men with asymptomatic chlamydial infection. J Androl 2004;25: 104-109.
6. Vigil P, Morales P, Tapia A, et al. Chlamydia trachomatis infection in male partners of infertile couples: incidence and sperm function. Andrologia 2002;34:155-161.
7. Bezold G, Politch JA, Kiviat NB, et al. Prevalence of sexually transmissible pathogens in semen from asymptomatic male infertility patients with and without leukocytospermia. Fertil Steril 2007;87:1087-1097.
8. Idahl A, Boman J, Kumlin U, et al. Demonstration of Chla-mydia trachomatis IgG antibodies in the male partner of the infertile couple is correlated with a reduced likelihood of achieving pregnancy. Hum Reprod 2004;19:1121-1126
9. Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance 2006 Supplement, Gonococcal Isolate Surveillance Project (GISP) Annual Report 2006. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, April 2008.
10. Ness RB, Markovic N, Carlson CL, et al. Do men become infertile after having sexually transmitted urethritis? An epi-demiologic examination. Fertil Steril 1997;68:205-213.
11. WHO Report 2008. Global tuberculosis control-surveillance, planning, financing. Available at: http://www.who.int/tb/ publications/global report/2008/en/. Accessed October 28, 2008.
12. Lenk S, Schroeder J. Genitourinary tuberculosis. Curr Opin Urol 2001;11:93-98.
13. Paick J, Kim SH, Kim SW. Ejaculatory duct obstruction in infertile men. BJU Int 2000;85:720-724.
14. Masarani M, Wazait H, Dinneen M. Mumps orchitis. J R Soc Med 2006;99:573-575.
15. Bartak V. Sperm count, morphology, and motility after unilateral mumps orchitis. J Reprod Fertil 1973;32:491-493.
16. Casella R, Leibundgut B, Lehmann K, et al. Mumps orchitis: report of a mini-epidemic. J Urol 1997;158:2158-2161.
17. Coll O, Lopez M, Vidal R, et al. Fertility assessment in non-infertile HIV-infected women and their partners. Reprod Biomed Online 2007;14:488-494.
18. Politch JA, Mayer KH, Abbott AF, et al. The effects of disease progression and zidovudine therapy on semen quality in human immunodeficiency virus type 1 seropositive men. Fer-til Steril 1994;61:922-928.
19. Nicopoullos JD, Almeida PA, Ramsay JW, et al. The effect of human immunodeficiency virus on sperm parameters and the outcome of intrauterine insemination following sperm washing. Hum Reprod 2004;19:2289-2297.
20. Gopalkrishnan K, Hinduja IN, Kumar TC. Semen characteristics of asymptomatic males affected by Trichomonas vagi-nalis. J In Vitro Fert Embryo Transf 1990;7:165-167.
21. Ochsendorf FR. Sexually transmitted infections: impact on male fertility. Andrologia 2008;40:72-75.
22. Kodaman PH, Arici A, Seli E. Evidence-based diagnosis and management of tubal factor infertility. Curr Opin Obstet Gy-necol 2004;16:221-229.
23. Paavonen J, Eggert-Kruse W. Chlamydia trachomatis: impact on human reproduction. Hum Reprod Update 1999;5: 433-447.
24. Simms I, Horner P. Has the incidence of pelvic inflammatory disease following chlamydial infection been overestimated? Int J STD AIDS 2008;19:285-286.
25. Lyons RA, Saridogan E, Djahanbakhch O. The reproductive significance of human fallopian tube cilia. Hum Reprod Update 2006;12:363-372.
26. Svenstrup HF, Fedder J, Kristoffersen SE, et al. Mycoplasma genitalium, Chlamydia trachomatis, and tubal factor infertil-ity-a prospective study. Fertil Steril 2008;90:513-520.
27. Machado AC, Guimaraes EM, Sakurai E, et al. High titers of Chlamydia trachomatis antibodies in Brazilian women with tubal occlusion or previous ectopic pregnancy. Infect Dis Obstet Gynecol 2007;2007:24816.
28. Akande VA, Hunt LP, Cahill DJ, et al. Tubal damage in infertile women: prediction using chlamydia serology. Hum Reprod 2003;18:1841-1847.
29. Wallace LA, Scoular A, Hart G, et al. What is the excess risk of infertility in women after genital chlamydia infection? A systematic review of the evidence. Sex Transm Infect 2008; 84:171-175.
30. Chow JM, Yonekura ML, Richwald GA, et al. The association between Chlamydia trachomatis and ectopic pregnancy. JAMA 1990;263:3164-3167.
31. Goyaux N, Leke R, Keita N, et al. Ectopic pregnancy in African developing countries. Acta Obstet Gynecol Scand 2003;82:305-312.
32. World Health Organization Task Force on the Prevention and Management of Infertility. Tubal infertility: serologic relationship to past chlamydial and gonococcal infection. Sex Transm Dis 1995;22:71-77.
33. The WHO Reproductive Health Library. Interventions for tubal ectopic pregnancy. Available at: http://www.who.int/ rhl/gynaecology/lmcom2/en/. Accessed May 25, 2008.
34. Wiesenfeld HC, Cates W. Sexually transmitted diseases and infertility. In: Holmes K, Sparling PF, Stamm WE, et al, eds. Sexually Transmitted Infections. 4th ed. New York, NY: McGraw Hill, 2008:1517.
35. Grodstein F, Goldman MB, Cramer DW. Relation of tubal infertility to history of sexually transmitted diseases. Am J Epidemiol 1993;137:577-584.
36. Ojo BA, Akanbi AA, Odimayo MS, et al. Endometrial tuberculosis in the Nigerian middle belt: an eight-year review. Trop Doct 2008;38:3-4.
37. Shaheen R, Subhan F, Tahir F. Epidemiology of genital tuberculosis in infertile population. J Pak Med Assoc 2006;56: 306-309.
38. Sharma JB, Roy KK, Pushparaj M, et al. Laparoscopic findings in female genital tuberculosis. Arch Gynecol Obstet 2008;278:359-364.
39. Glynn J, Buve A, Carael M, et al. Decreased fertility among HIV-1-infected women attending antenatal clinics in three African cities. J Acquir Immune Defic Syndr 2000;25:1717-1725.
40. Clark R, Mulligan K, Stamenovic E, et al. Frequency of anovulation and early menopause among women enrolled in selected AIDS clinical trials group studies. J Infect Dis 2001; 184:1325-1327.
41. Chirgwin K, Feldman J, Muneyyirci-Delale O, et al. Menstrual function in HIV-infected women without AIDS. J Acquir Immune Defic Syndr Hum Retrovirol 1996;12:489-494.
42. Harlow S, Schuman P, Cohen M, et al. Effect of HIV infection on menstrual cycle length. J Acquir Immune Defic Syndr 2000;24:68-75.
43. Siefer DB, Golub ET, Lambert-Messerlian G, et al. Biologic markers of ovarian reserve and reproductive aging: application in a cohort study of HIV infection in women. Fertil Steril 2007;88:1645-1652.
44. Blanc WA. Pathology of the placenta, membranes, and umbilical cord in bacterial, fungal, and viral infections in man. Monogr Pathol 1981;22:67-132.
45. Chellam VG, Rushton DI. Chorioamnionitis and funiculitis in the placentas of 200 births weighing less than 2.5 kg. Br J Obstet Gynaecol 1985;92:808-814.
46. Mueller-Heubach E, Rubinstein DN, Schwarz SS. Histologic chorioamnionitis and preterm delivery in different patient populations. Obstet Gynecol 1990;75:622-626.
47. Salafia CM, Vogel CA, Vintzileos AM, et al. Placental pathologic findings in preterm birth. Am J Obstet Gynecol 1991; 165:934-938.
48. Hitti J, Watts HD. Bacterial sexually transmitted infections in pregnancy. In: Holmes K, Sparling PF, Stamm WE, et al, eds. Sexually Transmitted Infections. 4th ed. New York, NY: McGraw Hill, 2008:1537.
49. Simcox R, Sin WT, Seed PT, et al. Prophylactic antibiotics for the prevention of preterm birth in women at risk: a meta-analysis. Aust N Z J Obstet Gynaecol 2007;47:368-377.
50. Iams JD, Romero R, Culhane JF, et al. Primary, secondary, and tertiary interventions to reduce the morbidity and mortality of preterm birth. Lancet 2008;371:164-175.
51. Blas MM, Canchihuaman FA, Alva IE, et al. Pregnancy outcomes in women infected with Chlamydia trachomatis: a population-based cohort study in Washington State. Sex Transm Infect 2007;83:314-318.
52. Germain M, Krohn MA, Hillier SL, et al. Genital flora in pregnancy and its association with intrauterine growth retardation. J Clin Microbiol 1994;32:2162-2168.
53. Donders GG, Desmyter J, De Wet DH, et al. The association of gonorrhea and syphilis with premature birth and low birth weight. Genitourin Med 1993;69:98-101.
54. Elliott B, Brunham RC, Laga M, et al. Maternal gonoccocal infection as a preventable risk factor for low birth weight. J Infect Dis 1990;161:531-536.
55. Christian L, Khatry SK, LeClerq SC, et al. Prevalence and risk factors of chlamydia and gonorrhea among rural Nepali women. Sex Transm Infect 2005;81:254-258.
56. Nygren P, Fu R, Freeman M, et al. Evidence on the benefits and harms of screening and treating pregnant women who are asymptomatic for bacterial vaginosis: an update review for the US Preventive Services Task Force. Ann Intern Med 2008;148:220-233.
57. Leitich H, Bodner-Adler B, Brunbauer M, et al. Bacterial vaginosis as a risk factor for preterm delivery: a meta-analysis. Am J Obstet Gynecol 2003;189:139-147.
58. Swadpanich U, Lumbiganon P, Prasertcharoensook W, et al. Antenatal lower genital tract infection screening and treatment programs for preventing preterm delivery. Cochrane Database Syst Rev 2008:CD006178.
59. Brocklehurst P, Hannah M, McDonald H. Interventions for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev 2003:CD000262.
60. Hauth JC, Goldenberg RL, Andrews WW, et al. Reduced incidence of preterm delivery with metronidazole and eryth-romycin in women with bacterial vaginosis. N Engl J Med 1995;333:1732-1736.
61. McDonald HM, O'Loughlin JA, Vigneswaran R, et al. Impact of metronidazole therapy on preterm birth in women with bacterial vaginosis flora (Gardnerella vaginalis): a randomized, placebo controlled trial. Br J Obstet Gynaecol 1997; 104:1391-1397.
62. Morales WJ, Schorr S, Albritton J. Effect of metronidazole in patients with preterm birth in preceding pregnancy and bacterial vaginosis: a placebo-controlled, double-blind study. Am J Obstet Gynecol 1994;171:345-349.
63. Boggess KA. Maternal oral health in pregnancy. Obstet Gy-necol 2008;111:976-986.
64. Offenbacher S, Katz V, Fertik G, et al. Periodontal infection as a possible risk factor for preterm low birth weight. J Periodontol 1996;67:1103-1113.
65. Jeffcoat MK, Geurs NC, Reddy MS, et al. Periodontal infection and preterm birth: results of a prospective study. J Am Dent Assoc 2001;132:875-880.
66. Klebanoff K, Searle K. The role of inflammation in preterm birth-focus on periodontitis. Br J Obstet Gynaecol 2006;113: 43-45.
67. Shafii T, Radolf JD, Sanchez PJ, et al. Congenital syphilis. In: Holmes K, Sparling PF, Stamm WE, et al, eds. Sexually Transmitted Infections. 4th ed. New York, NY: McGraw Hill, 2008:1584.
68. Woods CR. Syphilis in children: congenital and acquired. Semin Pediatr Infect Dis 2005;16:245-257.
69. Doroshenko A, Sherrard J, Pollard AJ. Syphilis in pregnancy and the neonatal period. Int J STD AIDS 2006;17:221-227.
70. Stegmann B, Carey J. TORCH infections: toxoplasmosis, other (syphilis, varicella-zoster, parvovirus B19), rubella, cy-tomegalovirus (CMV), and herpes infections. Curr Womens Health Rep 2002;2:253-258.
71. TORCH syndrome and TORCH screening. Lancet 1990;335: 1559-1561.
72. Brown KE, Young NS. Parvovirus B19 in human disease. Annu Rev Med 1997;48:59-67.
73. Valeur-Jensen AK, Pedersen CB, Westergaard T, et al. Risk factors for parvovirus B19 infection in pregnancy. JAMA 1999;281:1099-1105.
74. Public Health Laboratory Service Working Party on Fifth Disease. Prospective study of human parvovirus (B19) infection in pregnancy. BMJ 1990;300:1166-1170.
75. ACOG Committee on Practice Bulletins. ACOG Practice Bulletin: Perinatal Viral and Parasitic Infections. Washington, DC: ACOG; 2000. Number 20.
76. De Santis M, Cavaliere AF, Straface G, et al. Rubella infection in pregnancy. Reprod Toxicol 2006;21:390-398.
77. Cutts FT, Robertson SE, Diaz-Ortega JL, et al. Control of rubella and congenital rubella syndrome (CRS) in developing countries, part I: burden of disease from CRS. Bull World Health Organ 1997;75:55-68.
78. Ross D, Dollard S, Victor M, et al. The epidemiology and prevention of congenital cytomegalovirus infection and disease: activities of the Center for Disease Control and Prevention Workgroup. J Womens Health 2006;15:224-229.
79. Kenneson A, Cannon M. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol 2007;17:253-276.
80. Sauerbrei A, Wutzler P. Herpes simplex and varicella-zoster virus infections during pregnancy: current concepts of prevention, diagnosis, and therapy. Part 1: herpes simplex virus infections. Med Microbiol Immunol 2007;196:89-94. (Pubitemid 46466352)
81. Brown ZA, Selke S, Zeh J, et al. The acquisition of herpes simplex during pregnancy. N Engl J Med 1997;337:509-515.
82. Rawlinson WD, Hall B, Jones CA, et al. Viruses and other infections in stillbirth: what is the evidence and what should we be doing? Pathology 2008;40:149-160.
83. Thiebaut R, Leproust S, Chene G, et al. Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients' data. Lancet 2007;369:115-122.
84. Montoya JG, Remington JS. Management of Toxoplasma gondii infection during pregnancy. Clin Infect Dis 2008;47: 554-566.
85. Desai M, ter Kuile FO, Nosten F, et al. Epidemiology and burden of malaria in pregnancy. Lancet Infect Dis 2007;7:93-104.
86. Guyatt HL, Snow RW. Malaria in pregnancy as an indirect cause of infant mortality in sub-Saharan Africa. Trans R Soc Trop Med Hyg 2001;95:569-576.
87. Steketee RW, Nahlen BL, Parise ME, et al. The burden of malaria in pregnancy in malaria-endemic areas. Am J Trop Med Hyg 2001;64(suppl 1-2):28-35.
88. Brabin BJ, Romagosa C, Abdelgalil S, et al. The sick placen-ta-the role of malaria. Placenta 2004;25:359-378.
89. Guyatt HL, Snow RW. Impact of malaria during pregnancy on low birth weight in sub-Saharan Africa. Clin Microbiol Rev 2004;17:760-769.
90. Landis SH, Lokomba V, Ananth CV, et al. Impact of maternal malaria and under-nutrition on intrauterine growth restriction: a prospective ultrasound study in Democratic Republic of Congo. Epidemiol Infect 2008;137:294-304.
91. Sullivan AD, Nyirenda T, Cullinan T, et al. Malaria infection during pregnancy: intrauterine growth retardation and pre-term delivery in Malawi. J Infect Dis 1999;179:1580-1583.
92. Verhoeff FH, Brabin BJ, van Burren S, et al. An analysis of intra-uterine growth retardation in rural Malawi. Eur J Clin Nutr 2001;55:682-689.
93. Steketee RW, Wirima JJ, Hightower AW, et al. The effect of malaria and malaria prevention in pregnancy on offspring birthweight, prematurity, and intrauterine growth retardation in rural Malawi. Am J Trop Med Hyg 1996; 55(suppl 1):33-41.
94. Rogerson S, Hviid L, Duffy PE, et al. Malaria in pregnancy: pathogenesis and immunity. Lancet Infect Dis 2007;7:105-117.
95. Hammerschlag MR. Chlamydia trachomatis and Chlamydia pneumoniae infections in children and adolescents. Pediatr Rev 2004;25:43-51.
96. Brocklehurst P, Rooney G. Interventions for treating genital Chlamydia trachomatis infection in pregnancy. Cochrane Database Syst Rev 2000:CD000054.
97. Schachter J, Grossman M, Sweet RL, et al. Prospective study of perinatal transmission of Chlamydia trachomatis. JAMA 1986;255:3374-3377.
98. Smith JR, Taylor-Robinson D. Infection due to Chlamydia trachomatis in pregnancy and the newborn. Baillieres Clin Obstet Gynaecol 1993;7:237-255.
99. Laga M, Meheus A, Piot P. Epidemiology and control of gonococcal opthalmia neonatorum. Bull World Health Organ 1989;67:471-477.
100. Brocklehurst P. Antibiotics for gonorrhea in pregnancy: a review. Cochrane Database Syst Rev 2002:CD000098.
101. MacDonald N, Mailman T, Desai S. Gonococcal infections in newborns and in adolescents. Adv Exp Med Biol 2008;609: 108-130.
102. Schrag S, Gorwitz R, Fultz-Butts K, et al. Prevention of perinatal group B streptococcal disease: revised guidelines from CDC. MMWR Recomm Rep 2002;51(R-11):1-22.
103. Larsen JW, Sever JL. Group B streptococcus and pregnancy: a review. Am J Obstet Gynecol 2008;198:440-448.
104. Yow MD, Mason EO, Leeds LJ, et al. Ampicillin prevents intrapartum transmission of group B streptococcus. JAMA 1979;1245-1247.
105. Rouse DJ, Goldenberg RL, Cliver SP, et al. Strategies for the prevention of early-onset neonatal group B streptococcal sepsis: a decision analysis. Obstet Gynecol 1994;83:483-494.
106. Yancey MK, Schuchat A, Brown LK, et al. The accuracy of late antenatal screening cultures in predicting genital group B streptococcal colonization at delivery. Obstet Gynecol 1996;88:811-815.
107. Manning SD, Foxman B, Pierson DL, et al. Correlates of antibiotic-resistant group B streptococcus isolated from pregnant women. Am J Obstet Gynecol 2003;101:74-79.
108. ACOG Committee on Practice Bulletins. ACOG Practice Bulletin: Viral Hepatitis in Pregnancy. Washington, DC: ACOG, 2007. Number 86.
109. Watts DH. Pregnancy and virally sexually transmitted infections. In: Holmes K, Sparling PF, Stamm WE, et al, eds. Sexually Transmitted Infections. 4th ed. New York, NY: McGraw Hill, 2008:1572-1573.
110. Hill JB, Sheffield JS, Kim MJ, et al. Risk of hepatitis B transmission in breast-fed infants of chronic hepatitis B carriers. Obstet Gynecol 2002;99:1049-1052.
111. Wang J, Zhu Q, Zhang X. Effect of delivery mode on maternal-infant transmission of hepatitis B virus by immunopro-phylaxis. Chin Med J 2002;115:1510-1512.
112. Morrison EA, Gammon MD, Goldberg GL, et al. Pregnancy and cervical infection with human papillomaviruses. Int J Gynaecol Obstet 1996;54:125-130.
113. Tenti P, Zappatore R, Migliora P, et al. Perinatal transmission of human papillomavirus from gravidas with latent infections. Obstet Gynecol 1999;93:475-479.
114. Watts DH. Pregnancy and virally sexually transmitted infections. In: Holmes K, Sparling PF, Stamm WE, et al, eds. Sexually Transmitted Infections. 4th ed. New York, NY: McGraw Hill, 2008:1571.
115. Tseng CJ, Liang CC, Soong YK et al. Perinatal transmission of human papillomavirus in infants: relationship between infection rate and mode of delivery. Obstet Gynecol 1998; 91:92-96.
116. Bradford RD, Whitley RJ, Stagno S. Herpes virus infections in neonates and children: cytomegalovirus and herpes simplex virus. In: Holmes K, Sparling PF, Stamm WE, et al, eds. Sexually Transmitted Infections. 4th ed. New York, NY: McGraw Hill, 2008:1634.
117. Griffiths PD, Walter S. Cytomegalovirus. Curr Opin Infect Dis 2005;18:241-245.
118. Hollier LM, Wendel GD. Third trimester antiviral prophylaxis for preventing maternal genital herpes simplex virus (HSV) recurrences and neonatal infection. Cochrane Database Syst Rev 2008:CD004946.
119. Gupta R, Warren T, Wald A. Genital herpes. Lancet 2007; 370:2127-2137.
120. Dao H, Mofenson LM, Ekpini R, et al. International recommendations on antiretroviral drugs for treatment of HIV-infected women and prevention of mother-to-child HIV transmission in resource-limited settings: 2006 update. Am J Obstet Gynecol 2007;197:S42-S55.
121. Surjushe A, Maniar J. Prevention of mother-to-child transmission. Indian J Dermatol Venereol Leprol 2008;74:200-207.
122. Welles SL, Pitt J, Colgrove R, et al; The Women and Infants Transmission Study Group. HIV-1 genotypic zidovudine drug resistance and the risk of maternal-infant transmission in the women and infants transmission study. AIDS 2000;14:263-271.
123. Croly-Labourdette S, Vallet S, Gagneur A, et al. Pilot epide-miologic study of transmission of cytomegalovirus from mother to preterm infant by breast feeding. Arch Pediatr Adolesc Med 2006;13:1015-1021.
124. Jim WT, Chu CH, Chiu NC, et al. Transmission of cytomeg-alovirus from mothers to preterm infants by breast milk. Pediatr Infect Dis J 2004;23:848-851.
125. Hays S. Cytomegalovirus, breast feeding and prematurity. Arch Pediatr Adolesc Med 2007;1:S2-S4.
126. Neuberger P, Hamprecht K, Vochem M, et al. Case-control study of symptoms and neonatal outcome of human milk-transmitted cytomegalovirus infection in premature infants. J Pediatr 2006;148:326-331.
127. Kourtis AP, Jamieson DJ, de Vicenzi I, et al. Prevention of human immunodeficiency virus-1 transmission to the infant through breast feeding: new developments. Am J Obstet Gynecol 2007;197:S113-S122.
128. Coovadia HM, Rollins NC, Bland RM, et al. Mother-to-child transmission of HIV-1 infection during exclusive breastfeeding in the first 6 months of life: an intervention cohort study. Lancet 2007;369:1107-1116.